308 related articles for article (PubMed ID: 27638770)
1. Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.
Rasti A; Abolhasani M; Zanjani LS; Asgari M; Mehrazma M; Madjd Z
J Cancer Res Clin Oncol; 2017 Jan; 143(1):95-104. PubMed ID: 27638770
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
6. Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Rasti A; Shariftabrizi A; Mehrazma M; Fodstad Ø; Asgari M
Pathology; 2019 Jan; 51(1):21-31. PubMed ID: 30466948
[TBL] [Abstract][Full Text] [Related]
7. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.
Zanjani LS; Madjd Z; Abolhasani M; Rasti A; Fodstad O; Andersson Y; Asgari M
Biomark Med; 2018 Jan; 12(1):45-61. PubMed ID: 29243496
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of caveolin-1 in renal neoplasms.
Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
[TBL] [Abstract][Full Text] [Related]
11. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases.
Maas M; Kurcz A; Hennenlotter J; Scharpf M; Fend F; Walz S; Stühler V; Todenhöfer T; Stenzl A; Bedke J; Rausch S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982302
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic expression of B7-H3 and membranous EpCAM expression are associated with higher grade and survival outcomes in patients with clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Axcrona U; Abolhasani M; Rasti A; Asgari M; Fodstad Ø; Andersson Y
Ann Diagn Pathol; 2020 Jun; 46():151483. PubMed ID: 32143173
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the KIT/stem cell factor axis in renal tumours.
Horstmann M; Hennenlotter J; Geiger LM; Vogel U; Schmid H; Kuehs U; Stenzl A; Bedke J
Anticancer Res; 2012 Oct; 32(10):4339-45. PubMed ID: 23060556
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma.
Li G; Badin G; Zhao A; Gentil-Perret A; Tostain J; Péoc'h M; Gigante M
Histol Histopathol; 2013 Sep; 28(9):1217-22. PubMed ID: 23609324
[TBL] [Abstract][Full Text] [Related]
19. Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?
Horstmann M; Geiger LM; Vogel U; Schmid H; Hennenlotter J; Kuehs U; Merseburger AS; Kruck S; Stenzl A; Bedke J
World J Urol; 2012 Aug; 30(4):525-31. PubMed ID: 21928123
[TBL] [Abstract][Full Text] [Related]
20. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]